LYN and chronic myelogenous leukemia, BCR-ABL1 positive: During apoptosis in B cells, T cells and the CML cell line K562, Lyn is cleaved in its N-terminal SH4 domain by caspase-3 after aspartate 18, exposing a leucine as the new N-termini[11-13].